A Predominantly Clonal Multi-Institutional Outbreak of<i>Clostridium difficile</i>–Associated Diarrhea with High Morbidity and Mortality

Vivian G. Loo, Louise Poirier, Mark A. Miller, +16

New England Journal of Medicine

Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas

Ryan D. Morin, Sarit Assouline, Miguel Alcaide, +29

Clinical Cancer Research

The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells

JV Raelson, Clara Nervi, Andreas Rosenauer, +4

Blood

Quantitative Real-Time Reverse Transcription-PCR Assay for Cyclin D1 Expression: Utility in the Diagnosis of Mantle Cell Lymphoma

Karen E. Bijwaard, Nadine S. Aguilera, Yury Monczak, +3

Clinical Chemistry

Inhibition of CCAAT/Enhancer-binding Protein α and β Translation by Upstream Open Reading Frames

A. Jeannine Lincoln, Yury Monczak, Simon C. Williams, +1

Journal of Biological Chemistry

Brief report: Killer cell defect and persistent immunological abnormalities in two patients with chronic active epstein‐barr virus infection

J. H. Joncas, Yury Monczak, F Ghibu, +4

Journal of Medical Virology

Comparison of PCR and Culture for Screening of Vancomycin-Resistant Enterococci: Highly Disparate Results for <i>vanA</i> and <i>vanB</i>

Anton Mak, Mark A. Miller, George Chong, +1

Journal of Clinical Microbiology

Antimicrobial Resistance GeneAntimicrobial SusceptibilityHealth SciencesAntibioticsPathogen Detection +12

Identification of a new common provirus integration site in gross passage A murine leukemia virus-induced mouse thymoma DNA.

Richard Villemur, Yury Monczak, Éric Rassart, +2

Molecular and Cellular Biology

Restriction MapViral ReplicationMolecular VirologyImmunologyDna Replication +12

Induction of Apoptosis Without Differentiation by Retinoic Acid in PLB-985 Cells Requires the Activation of Both RAR and RXR

Yury Monczak, Michel Trudel, William W. Lamph, +1

Blood

Bone marrow mesenchymal stromal cells of patients with myeloproliferative disorders do not carry the JAK2-V617F mutation

François Mercier, Yury Monczak, Moïra François, +2

Experimental Hematology

Hematological MalignancyBone Marrow FailureMedicineMyeloproliferative DisordersHematology +9